What is it about?
This study investigated the potential use of DW-MRI through its ADC data to analyze the predictive response in rectal cancer patients undergoing neoadjuvant therapy. The work was designed to statistically evaluate whether ADC quantitative values can indeed provide an enhanced diagnostic biomarker of response.
Featured Image
Why is it important?
The use of post-CRT ADC increased the diagnostic performance of standard MRI, improving the accuracy of predicting the final pathologic staging of rectal carcinoma
Perspectives
In the future, larger studies may separate these populations with greater precision, revealing and making clear the area of interception between the pathologic complete response and non-pathologic complete response groups.
Thiago Bassaneze
Read the Original
This page is a summary of: Quantitative aspects of diffusion-weighted magnetic resonance imaging in rectal cancer response to neoadjuvant therapy, Radiology and Oncology, June 2017, De Gruyter,
DOI: 10.1515/raon-2017-0025.
You can read the full text:
Contributors
The following have contributed to this page
